Volume 65, Issue 5, Pages (November 2016)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 Trial

Volume 61, Issue 2, Pages (August 2014)

Phase 3 Treatment-Naïve and Treatment-Experienced

Volume 63, Issue 1, Pages (July 2015)

Volume 53, Issue 1, Pages (July 2010)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen? Patrick Marcellin, E. Jenny Heathcote,

Volume 68, Issue 5, Pages (May 2018)

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Volume 42, Issue 1, Pages (January 2005)

NS5A inhibitors in the treatment of hepatitis C

Volume 69, Issue 4, Pages (October 2018)

Volume 42, Issue 5, Pages (May 2005)

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Immigration and viral hepatitis

Virological tools to diagnose and monitor hepatitis C virus infection

Living donor liver transplantation: is the hype over?

David G. Bowen, Christopher M. Walker Journal of Hepatology

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

Autoimmune hepatitis: A life-long disease

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

European Association for the Study of the Liver Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Autophagy in the liver Journal of Hepatology

EASL Clinical Practice Guidelines: Wilson’s disease

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Martina Gambato, Sabela Lens, Miquel Navasa, Xavier Forns

Volume 65, Issue 2, Pages (August 2016)

EASL Clinical Practice Guidelines on hepatitis E virus infection

Volume 67, Issue 5, Pages (November 2017)

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

miR-122 – A key factor and therapeutic target in liver disease

Volume 70, Issue 1, Pages (January 2019)

Immigration and viral hepatitis

HCV targeting of patients with cirrhosis

Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin? Lawrence.

Volume 63, Issue 1, Pages (July 2015)

Volume 51, Issue 2, Pages (August 2009)

Alessio Aghemo, Maria Francesca Donato Gastroenterology

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Volume 70, Issue 3, Pages (March 2019)

Chimeric mouse model of hepatitis B virus infection

Volume 62, Issue 5, Pages (May 2015)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 65, Issue 5, Pages 1063-1065 (November 2016) Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease Julien Vionnet, Anne-Catherine Saouli, Manuel Pascual, Fabien Stucker, Laurent Arthur Decosterd, Darius Moradpour, Haithem Chtioui Journal of Hepatology Volume 65, Issue 5, Pages 1063-1065 (November 2016) DOI: 10.1016/j.jhep.2016.06.032 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 GS331007 and DCV plasma trough concentrations over 24weeks of treatment in patient 1 (○) and patient 2 (■; predialysis: regular line and post dialysis: dotted line). The grey zones indicate the usually expected steady state plasma trough concentrations range for DCV 60mg qd and for GS331007 (SOF 400mg qd) in treatment-naive patients with chronic HCV genotype 1 infection. Journal of Hepatology 2016 65, 1063-1065DOI: (10.1016/j.jhep.2016.06.032) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions